Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

NCT00090168 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

435

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Atherosclerotic Disease
Coronary Disease

Interventions

DRUG: MK0653A , ezetimibe (+) simvastatin
DRUG: Comparator: atorvastatin
DRUG: Duration of Treatment: 6 weeks

Sponsor

Organon and Co